Thursday, July 30, 2020 5:22:51 AM
?
Published
2 days ago
on
July 28, 2020
By
Melissa Kay
Kaya Brands International, Inc. (KBI), an auxiliary of Kaya Holdings Inc (OTCMKTS:KAYS), along with its JV partner – Greekkannabis (GKC) will roll out cannabidiol pet products under the brand – Cannamo in Greece and adjoining nations in Europe.
Involves Day Three Labs
KBI developed the Cannomo brand to satisfy the demand identified by GKC. The company also involved Day Three Labs (DTL), a company based in Israeli, developing the Cannamo brand.
GKC will contribute experience gained in the pet supplement and pet food industry in Greece for the success of this innovative brand. The three partners will play a vital role in introducing the Cannamo brand and facilitating its penetration.
Craig Frank, CEO of Kayak, said the Cannamo brand is a result of the three players’ broader cooperation to establish a large company for global expansion. The three leading players leveraged their strengths in the development and commercialization of the Cannamo brand and make its implementation simple and effective.
Kaya Kannabis, a JV between GKC and Kaya, will nurture relationships with customers for CBD products introduced by the team while rigorous efforts are put in to create a marketing strategy targeted at the EU. Co-founder of GKC, Elias Kammenos, said the launch of CBD pet products will generate revenue streams while a medical cannabis facility is constructed in Greece. It will also familiarize its brands in the EU because plans are underway to introduce THC products.
DTL’s principals – Rafi Cohen and Joshua Robin will be onboard the advisory panel to support the construction of the cultivation and processing project of Kayak in Israel. Craig said the company is excited to work with DTL on mutually beneficial projects. Kayak will benefit from product development and relationships in the scientific cannabis community of Israel.
Long time opportunity
Co-founder of GKC, Panos Kinnis, said their innovative ideas, approach, and vision helped expedite the launch of its products. It also offered a myriad of opportunities to cultivate growth. EU presents a long time demand for cannabidiol and medical cannabis products. GKC plans to go ahead with KBI to take an early lead and capitalize on the emerging opportunities to derive rich dividends.
The Greek government granted a cannabis installation license to GKC to commence Medical Cannabis Cultivation/ processing facility in Thebes, Greece. It will annually produce 225,000 pounds of medical cannabis products. Kayak established KBI to address global markets, leveraging its operational expertise.
https://mmjreporter.com/kaya-brands-international-inc-a-subsidiary-of-kaya-holdings-inc-otcmktskays-and-greekkannabis-will-introduce-cbd-pet-products-under-cannamo-brand-41046
Recent KAYS News
- Form 8-K - Current report • Edgar (US Regulatory) • 08/26/2024 08:05:12 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/22/2024 08:15:12 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/19/2024 08:55:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/15/2024 01:30:38 PM
- Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 08/01/2024 08:07:32 PM
- Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend] • Edgar (US Regulatory) • 08/01/2024 08:05:41 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/10/2024 09:30:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/07/2024 01:20:18 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/16/2024 08:32:45 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 12:30:26 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 02/15/2024 09:38:31 PM
- Investor Ideas Potcasts: Interview with Kaya Holdings (OTCQB: KAYS) on the Sacred Mushroom Center - Pioneers with Psilocybin and Advocates for Mental Health • InvestorsHub NewsWire • 11/28/2023 12:00:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:25:51 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 01:30:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/23/2023 08:15:17 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 11:48:09 AM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM